Avillion announces positive high-level results from Phase III BATURA trial with AstraZeneca’s inhaled anti-inflammatory medication Airsupra in asthma patients Independent Data Monitoring Committee recommended trial stop early due to overwhelming efficacy at pre-planned analysisPhase IIIb clinical development of Airsupra was conducted by Avillion under an...